Add Yahoo as a preferred source to see more of our stories on Google. We might earn a commission if you make a purchase through one of the links. The McClatchy/Merced Sun-Star Commerce Content team, ...

With Mira-55 and Ketamir-2, MIRA is advancing complementary non-opioid therapies for two of the largest pain markets Mira-55 is a next-generation analog of marijuana, engineered to selectively ...

Advanced Radiation Centers of New York (ARC) has introduced SoftRay(TM) therapy, a non-invasive treatment designed to reduce inflammation and pain associated with arthritis and other degenerative ...

Demonstrates ART26.12’s Differentiated Profile as a Promising Pain Treatment Ahead of Planned Multiple Ascending Dose Study This YearPhase 1 SAD ...

Ken Hsu and collaborators are working towards a non-addictive painkiller using a novel way to shut off inflammation. An artistic depiction of energy metabolism in cells which is also regulated by ...

Over-the-counter (OTC) pain medication includes acetaminophen for treating pain and fever and nonsteroidal anti-inflammatory drugs (NSAIDs) for treating inflammatory conditions. These OTC pain relief ...

Many people suffer from painful arthritis and I'm one of them. Rather than treat my chronic pain with a host of OTC medications that have some nasty side effects, I prefer a more natural approach ...

Lenore Cangeloso is a board-certified acupuncturist and herbal medicine practitioner based in Oregon. She graduated with honors from Oregon College of Oriental Medicine in 2016 and obtained her ...

Understanding Joint Pain and Its Causes Do you frequently experience pain in your knees, back, shoulders, or joints? Have you ...

Leah Suzanne is a professional writer with decades of experience covering health, wellness and fitness. From interviewing top experts about the COVID-19 pandemic to asking sought-after celebrity ...

With Mira-55 and Ketamir-2, MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / July 3, 2025 / MIRA Pharmaceuticals, Inc.